BCCIP Antikörper (AA 300-350)
Kurzübersicht für BCCIP Antikörper (AA 300-350) (ABIN1976967)
Target
Alle BCCIP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 300-350
-
Spezifität
- Region between residue 300 and 350 of human BRCA2 and CDKN1A interacting protein using the numbering given in entry NP_510868.1 (GeneID 56647).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IF (1:250 - 1:2000), IHC, IHC-P (1:500 - 1:2000), IP (2 - 5 μg/mg lysate)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Colon Carcinoma, Prostate Carcinoma, Testicular Seminoma.
Not recommended for: WB -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- BCCIP (BRCA2 and CDKN1A Interacting Protein (BCCIP))
-
Andere Bezeichnung
- BCCIP
-
Hintergrund
-
Name/Gene ID: BCCIP
Synonyms: BCCIP, BCCIPbeta, TOK-1alpha, TOK1, TOK-1, Protein TOK-1, BCCIPalpha, TOK-1beta -
Gen-ID
- 56647
Target
-